Kevin Seibert, PhD

Vice President, Engineering, Synthetic Molecule Design and Development at Eli Lilly and Company

Speaker

Kevin Seibert is VP and Senior Engineering Fellow at Eli Lilly with over 30 years of pharmaceutical industry experience. He led the chemistry and engineering teams responsible for developing and commercializing Lilly's tirzepatide, pioneering a novel continuous manufacturing platform for synthetic peptides. Kevin was responsible for the development and commercialization of five marketed compounds, is a Fellow of AIChE and Past-Chair of the PD2M Forum, and has served on the IQ Consortium and Emerging Technologies Consortium Board of Directors. He is author or co-author of more than 80 technical publications, book chapters, and presentations, holds three patents, and earned his BS from the University of Colorado and MS/PhD from the University of Michigan.